J O Moore

Extramedullary leukemia adversely affects hematologic complete remission rate and overall survival in patients with t(8;21)(q22;q22): results from Cancer and Leukemia Group B 8461.

John C. Byrd, R B Weiss, D C Arthur et al. · Journal of Clinical Oncology · 1997 · 235 citations

Medicine, Hematology, Oncology +14

Conversion of a stem cell leukemia from a T-lymphoid to a myeloid phenotype induced by the adenosine deaminase inhibitor 2'-deoxycoformycin.

Michael S. Hershfield, Joanne Kurtzberg, E A Harden et al. · Proceedings of the National Academy of Sciences · 1984 · 165 citations

Medicine, Hematology, Oncology +15

CD7+, CD4-, CD8- acute leukemia: a syndrome of malignant pluripotent lymphohematopoietic cells

Joanne Kurtzberg, Waldmann Ta, MP Davey et al. · Blood · 1989 · 154 citations · Full text

Medicine, Immunology, Oncology +11

Clinical and pharmacologic effects of high dose single agent busulfan with autologous bone marrow support in the treatment of solid tumors.

W. P. Peters, W. David Henner, L B Grochow et al. · PubMed · 1987 · 73 citations

Medicine, Oncology, Pharmacology +13

Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.

David H. Henry, Beth Brooks, D. Case et al. · PubMed · 2006 · 72 citations

Medicine, Hematology, Pharmacology +16